Literature DB >> 15660577

Anthropometric and body composition assessment in dialysis patients.

William C Chumlea1.   

Abstract

Anthropometric and body composition assessments provide important information about the nutritional status of dialysis patients. Anthropometric measurements describe body size, fatness, and leanness in dialysis patients and have been collected in the Modification of Diet in Renal Disease (MDRD) and HEMO studies. Dialysis patients present special problems for anthropometry, including decreased functional status and increased comorbidity, that challenge nutrition assessment methodology. Recumbent anthropometric techniques are recommended and stature is estimated from knee height. Measures of weight, stature, calf circumference, arm circumference, and triceps and subscapular skinfolds have recently been reported for dialysis patients, who tend to be shorter, lighter, and have less adipose tissue than healthy persons of the same age. The HEMO study anthropometric data provide a clinical reference for assessing the nutritional status of dialysis patients. The most common body composition methods used with dialysis patients are dual energy X-ray absorptiometry (DEXA), bioelectrical impedance, total body water (TBW), and prediction equations, but they are not recommended for assessment of predialysis patients, as estimates are best obtained postdialysis. The TBW volume used in calculating the dose of dialysis has commonly been predicted from the limited, out-of-date equations of Watson, based on nonrepresentative samples. New prediction equations are available for white, black, and Mexican American children and adults. Watson's data are not representative of the TBW of U.S. men and women. The greater TBW in non-Hispanic black men and women and Mexican American women reflects the greater levels of obesity in the U.S. population.

Entities:  

Mesh:

Year:  2004        PMID: 15660577     DOI: 10.1111/j.0894-0959.2004.17607.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  7 in total

1.  Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis.

Authors:  Nazanin Noori; Csaba P Kovesdy; Ramanath Dukkipati; Youngmee Kim; Uyen Duong; Rachelle Bross; Antigone Oreopoulos; Amanda Luna; Debbie Benner; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2010-09-15       Impact factor: 7.045

2.  Approaches to Obesity Management in Dialysis Settings: Renal Dietitian Perspectives.

Authors:  Aditi Suresh; Lucy Robinson; Brandy-Joe Milliron; Kristin Leonberg; Mara McAdams-DeMarco; Carrie Earthman; Ann Klassen; Meera N Harhay
Journal:  J Ren Nutr       Date:  2020-03-04       Impact factor: 3.655

3.  Comparison of nutritional parameters among adult and elderly hemodialysis patients.

Authors:  Gülperi Çelik; Bahar Oc; Inci Kara; Mümtaz Yılmaz; Ali Yuceaktas; Seza Apiliogullari
Journal:  Int J Med Sci       Date:  2011-10-13       Impact factor: 3.738

4.  Nutritional Status Predicts 10-Year Mortality in Patients with End-Stage Renal Disease on Hemodialysis.

Authors:  Shin Sook Kang; Jai Won Chang; Yongsoon Park
Journal:  Nutrients       Date:  2017-04-18       Impact factor: 5.717

5.  Assessment of nutritional status in the maintenance of haemodialysis patients: a cross-sectional study from Palestine.

Authors:  Ali M Omari; Leen S Omari; Hazar H Dagash; Waleed M Sweileh; Nehal Natour; Sa'ed H Zyoud
Journal:  BMC Nephrol       Date:  2019-03-15       Impact factor: 2.388

6.  Nutritional status and quality of life in diabetic patients on hemodialysis: a cross-sectional study from Palestine.

Authors:  Eba'a Hafi; Ro'ya Soradi; Sarah Diab; Ahmad M Samara; Marah Shakhshir; Malik Alqub; Sa'ed H Zyoud
Journal:  J Health Popul Nutr       Date:  2021-07-05       Impact factor: 2.000

7.  Relationship between the target dose for hemodialysis adequacy and nutritional assessment.

Authors:  Tezcan Kaya; Savas Sipahi; Hakan Cinemre; Cengiz Karacaer; Ceyhun Varim; Ahmet Nalbant; Ali Tamer
Journal:  Ann Saudi Med       Date:  2016-04-03       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.